Welcome to our dedicated page for Foxby news (Ticker: XFXBX), a resource for investors and traders seeking the latest updates and insights on Foxby stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Foxby's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Foxby's position in the market.
Foxby Corp. (Ticker: FXBY, NASDAQ: XFXBX) has announced a 1-for-5 reverse stock split, effective after market close on May 6, 2021. Each 5 outstanding shares will convert into 1 share, with trading starting on a split-adjusted basis on May 7, 2021. This move aims to boost the market price of the Fund's shares, without altering shareholders' ownership percentage or voting power. Fractional shares will be paid out in cash at the net asset value per share. The Fund continues to focus on total return through capital growth and income from diverse securities.